Magnetic labeling of activated microglia in experimental gliomas

Neoplasia

Volumn 3, Issue 6, 2001, Pages 489-499

  Fleige, Gerrit ^a   Nolte, Christiane ^b   Synowitz, Michael ^b   Seeberger, Florian ^a   Kettenmann, Helmut ^a   Zimmer, Claus ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Glioma; Magnetic cell labeling; Microglia; MRI; Superparamagnetic iron oxides (USPIO)

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL LABELING; CONTROLLED STUDY; EFFECTOR CELL; GLIOMA; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; MAGNETISM; MICROGLIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; PRIORITY JOURNAL; RAT;

EID: 0035215981     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900176     Document Type: Article

References (58)

1. Inaugural article: Positron emission tomography provides molecular imaging of biological processes
2. New probes open windows on gene expression
3. Molecular imaging: Exploring the next frontier
4. Quantification of target gene expression by imaging reporter gene expression in living animals
5. In vivo magnetic resonance imaging of transgene expression
6. The development of in vivo imaging systems to study gene expression
7. In vivo visualization of gene expression using magnetic resonance imaging
8. Near-infrared optical imaging of protease activity for tumor detection
9. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy
10. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging
11. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination
12. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
13. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
14. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity
15. In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET)
16. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment
17. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy
18. Magnetic resonance microscopy of the C57BL mouse brain
19. Detection of single mammalian cells by high-resolution magnetic resonance imaging
20. Microglial response to brain injury: A brief synopsis
21. The brain's immune system
22. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas
23. Distribution and characterization of microglia/macrophages in human brain tumors
24. Cellular immune response in brain tumors
25. 11C]PK1195
26. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies
27. Magnetically labeled cells can be detected by MR imaging
28. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance
29. Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION-46L enhanced in vivo MRI: Early histopathological correlation
30. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages
31. MR imaging of phagocytosis in experimental gliomas
32. Tumor cell endocytosis imaging facilitates delineation of the glioma-brain interface
33. Imaging macrophage activity in the brain by using ultrasmall particles of iron oxide
34. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model
35. Astrocyte-derived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages
36. Characterization of ameboid microglia isolated from developing mammalian brain
37. Rat brain tumor models in experimental neuro-oncology: The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas
38. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways
39. Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro
40. Phagocytozing ameboid microglial cells studied in a mouse corpus callosum slice preparation
41. Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration
42. Quinolinate immunoreactivity in experimental rat brain tumors is present in macrophages but not in astrocytes
43. Response of microglial cells to experimental rat glioma
44. Immunophenotypic analysis of infiltrating leukocytes and microglia in an experimental rat glioma
45. Monocyte subpopulations in human gliomas: Expression of Fc and complement receptors and correlation with tumor proliferation
46. Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors
47. Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro
48. Antigenpresenting capability of glial cells under glioma-harboring conditions and the effect of glioma-derived factors on antigen presentation
49. Microglial/macrophage expression of interleukin 10 in human glioblastomas
50. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor
51. Microglial phagocytosis is modulated by pro- and anti-inflammatory cytokines
52. Intracellular labeling of T-cells with superparamagnetic contrast agents
53. Cerebral iron oxide distribution: In vivo mapping with MR imaging
54. Superparamagnetic iron oxide: Pharmacokinetics and toxicity
55. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates
56. Inflammation and glial responses in ischemic brain lesions
57. Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis
58. Our approach towards developing a specific tumour-targeted MRI contrast agent for the brain